uniQure to Present at the 36th Cowen & Company Health Care Conference
March 02 2016 - 5:00AM
uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy,
announced today that its management will present at the 36th Cowen
& Company Healthcare Conference to be held on March 7 – 9, 2016
at the Boston Marriott Copley Place, Boston, Massachusetts.
Date: March 9, 2016
Time: 11:20 a.m. EST / 5:20 p.m. CET
Speaking for uniQure: Daniel Soland (Chief
Executive Officer)
The live webcast, including a slide presentation, can be
accessed through the following link:
http://wsw.com/webcast/cowen30/qure or by accessing the link
displayed in the "Events" section on the "Media" page of the
uniQure website at:
http://www.uniqure.com/news/calendar-of-events/. The replay of the
webcast will be available after the conclusion of the live event
and archived on the uniQure website for at least 30 days following
the webcast.
About uniQure
uniQure is delivering on the promise of gene therapy – single
treatments with potentially curative results. We are leveraging our
modular and validated technology platform to rapidly advance a
pipeline of proprietary and partnered gene therapies to treat
patients with CNS, liver/metabolic and cardiovascular diseases.
www.uniQure.com
CONTACT: uniQure:
Eva Mulder
Direct : +31 20 240 6103
Main: +31 20 240 6000
e.mulder@uniQure.com
Media inquiries:
Gretchen Schweitzer
MacDougall Biomedical Communications
Direct: +49 172 861 8540
Main: +49 89 2424 3494 or +1 781 235 3060
gschweitzer@macbiocom.com
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024